InvestorsHub Logo
Followers 10
Posts 504
Boards Moderated 0
Alias Born 04/20/2016

Re: gestalt2 post# 8564

Thursday, 12/29/2016 8:24:39 PM

Thursday, December 29, 2016 8:24:39 PM

Post# of 232169
Pourhassan must be replaced now. Regardless of how or why Pourhasssan got the job as Cytodyn's president, he should not be allowed to retain this job now as he does not have the experience,intellect, or disposition to bring this company to the finish line. Even worse, he is GROSSLY overpaid to the tune of millions of dollars per year. For that kind of money, Cytodyn could get a seasoned professional who has had a history of successes with clinical stage biopharma companies such as this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News